Atlas Trials

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

Clinical trial NCT05210179 · COMPLETED

Trial details

NCT number
NCT05210179
Sponsor
Health Institutes of Turkey
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
COVID-19Sars-CoV-2 Infection
Start date
2022-01-24
Primary completion
2023-02-25
Enrollment
65

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.